Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
ClinicalTrials.gov study NCT06651866. IPD Sharing: NO. Countries: 1. Publications: 0.
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07223814. IPD Sharing: YES. Countries: 0. Publications: 0.
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
ClinicalTrials.gov study NCT06552416. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients
ClinicalTrials.gov study NCT03823352. IPD Sharing: NO. Countries: 1. Publications: 0.
Single-Center Phase 1 Study With Escalating Doses of Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid Leukemia (AML). TOCIVENA
ClinicalTrials.gov study NCT07392814. IPD Sharing: NO. Countries: 1. Publications: 0.
ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AML
ClinicalTrials.gov study NCT06512610. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX
ClinicalTrials.gov study NCT06782971. IPD Sharing: NO. Countries: 1. Publications: 0.
Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
ClinicalTrials.gov study NCT00809250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04155580. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML
ClinicalTrials.gov study NCT06611839. IPD Sharing: Not stated. Countries: 0. Publications: 0.
PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years
ClinicalTrials.gov study NCT01296178. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML
ClinicalTrials.gov study NCT03250338. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML
ClinicalTrials.gov study NCT04365179. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML
ClinicalTrials.gov study NCT02238522. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes
ClinicalTrials.gov study NCT04861207. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
ClinicalTrials.gov study NCT06030089. IPD Sharing: NO. Countries: 1. Publications: 0.
Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT01422603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDS
ClinicalTrials.gov study NCT04044209. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01066494. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
ClinicalTrials.gov study NCT06950034. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.